Carr B R, Mason J I
Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas 75235.
Am J Obstet Gynecol. 1988 Dec;159(6):1361-5. doi: 10.1016/0002-9378(88)90556-x.
The human fetal adrenal gland is primarily composed of fetal zone cells, which exhibit a high rate of steroidogenesis and a rapid growth rate during fetal life. alpha-Human atrial natriuretic polypeptide has been shown to inhibit basal and adrenocorticotropic hormone-stimulated steroidogenesis in the human adult and in some human adrenal adenoma cells. The purpose of this investigation was to determine the effect of atrial natriuretic polypeptide on steroidogenesis by fetal zone cells. Dispersed fetal zone cells were incubated in Krebs-Ringer's medium with adrenocorticotropic hormone, forskolin, 22R-hydroxycholesterol, or dibutyryl cyclic adenosine monophosphate and in the presence of atrial natriuretic polypeptide. The medium was analyzed for content of dehydroepiandrosterone sulfate and cortisol by radioimmunoassay. The addition of adrenocorticotropic hormone, forskolin, 22R-hydroxycholesterol, or dibutyryl cyclic adenosine monophosphate increased the secretion of dehydroepiandrosterone sulfate and cortisol twofold to threefold and twofold to sixfold, respectively, above basal rates. Atrial natriuretic polypeptide significantly inhibited basal dehydroepiandrosterone sulfate and cortisol secretion. When cells were incubated in the presence of adrenocorticotropic hormone, forskolin, 22R-hydroxycholesterol, or dibutyryl cyclic adenosine monophosphate plus atrial natriuretic polypeptide, cortisol secretion was inhibited 50% to 90% and dehydroepiandrosterone sulfate was inhibited 25% to 50%. Atrial natriuretic polypeptide had no effect on the metabolism of progesterone tagged with carbon 14 in fetal zone cells. In conclusion, atrial natriuretic polypeptide inhibited basal and adrenocorticotropic hormone-stimulated steroid secretion by fetal zone cells. Furthermore, these results suggested that the action of atrial natriuretic polypeptide was by inhibition of cholesterol side-chain cleavage or transfer of cholesterol to the mitochondrion.
人类胎儿肾上腺主要由胎儿带细胞组成,这些细胞在胎儿期表现出高类固醇生成率和快速生长率。α-人心房利钠多肽已被证明可抑制成年人体内以及某些人肾上腺腺瘤细胞中基础的和促肾上腺皮质激素刺激的类固醇生成。本研究的目的是确定心房利钠多肽对胎儿带细胞类固醇生成的影响。将分散的胎儿带细胞在含有促肾上腺皮质激素、福斯可林、22R-羟基胆固醇或二丁酰环磷酸腺苷的Krebs-Ringer培养基中,并在心房利钠多肽存在的情况下进行孵育。通过放射免疫分析法分析培养基中硫酸脱氢表雄酮和皮质醇的含量。添加促肾上腺皮质激素、福斯可林、22R-羟基胆固醇或二丁酰环磷酸腺苷后,硫酸脱氢表雄酮和皮质醇的分泌分别比基础水平增加了两倍至三倍和两倍至六倍。心房利钠多肽显著抑制基础硫酸脱氢表雄酮和皮质醇的分泌。当细胞在促肾上腺皮质激素、福斯可林、22R-羟基胆固醇或二丁酰环磷酸腺苷加心房利钠多肽存在的情况下孵育时,皮质醇分泌被抑制50%至90%,硫酸脱氢表雄酮被抑制25%至50%。心房利钠多肽对胎儿带细胞中标记有碳14的孕酮代谢没有影响。总之,心房利钠多肽抑制胎儿带细胞基础的和促肾上腺皮质激素刺激的类固醇分泌。此外,这些结果表明心房利钠多肽的作用是通过抑制胆固醇侧链裂解或胆固醇向线粒体的转运。